Application Nr Approved Date Route Status External Links
NDA017588 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Gleostine Is An Alkylating Drug Indicated For The Treatment Of Patients With: Brain Tumors, Primary And Metastatic, Following Appropriate Surgical And/or Radiotherapeutic Procedures. ( 1 ) Hodgkin's Lymphoma In Combination With Other Chemotherapies, Following Disease Progression With Initial Chemotherapy. ( 1 ) 1.1 Brain Tumors Gleostine Is Indicated For The Treatment Of Patients With Primary And Metastatic Brain Tumors Following Appropriate Surgical And/or Radiotherapeutic Procedures. 1.2 Hodgkin's Lymphoma Gleostine Is Indicated As A Component Of Combination Chemotherapy For The Treatment Of Patients With Hodgkin's Lymphoma Whose Disease Has Progressed Following Initial Chemotherapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lomustine LOMUSTINE ZINC3831006

Comments